Broome Oncology

Lung Cancer - Small Cell News

Opdivo® (nivolumab) Approved for Treatment of Small Cell Lung Cancer (August 23, 2018)

The U.S. Food and Drug Administration (FDA) has approved Opdivo (nivolumab) for the treatment of metastatic small cell lung cancer (SCLC) whose cancer has progressed after platinum-based chemotherapy and at least one other line of therapy.1 About Small... Continue Reading

Precision Cancer Medicine PARP Inhibitor Promising Treatment for Small Cell Lung Cancer (June 25, 2018)

The results of a recent study published in The Journal of Clinical Oncology suggest the first new therapeutic option for Small Cell Lung Cancer (SCLC) in many years.  The study evaluated the addition of a novel precision cancer medicine called a PARP... Continue Reading

Latest Lung Cancer - Small Cell News By Stage


Extensive Lung Cancer - Small Cell

Sorry, there are no articles available for this cancer stage.

More Extensive Lung Cancer - Small Cell

Limited Disease Lung Cancer - Small Cell

Sorry, there are no articles available for this cancer stage.

More Limited Disease Lung Cancer - Small Cell

Recurrent Lung Cancer - Small Cell

Sorry, there are no articles available for this cancer stage.

More Recurrent Lung Cancer - Small Cell

Screening/Prevention Lung Cancer - Small Cell

Sorry, there are no articles available for this cancer stage.

More Screening/Prevention Lung Cancer - Small Cell